Download | < Back |
31 Oct 2020 | |
Press Release relating to 5-year sustained efficacy and safety results for ILUMYA? in patients with moderate-to-severe plaque psoriasis, which we shall be releasing after sending this letter to you. This is for your information and record.<BR> <BR> Thanking you,<BR> | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |